share_log

Core Laboratories Analyst Ratings

Core Laboratories Analyst Ratings

核心实验室分析师评级
Benzinga ·  2023/09/18 09:25
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/18/2023 -19.45% Citigroup $21 → $20 Maintains Sell
07/31/2023 -15.42% Piper Sandler $19 → $21 Maintains Neutral
06/30/2023 -15.42% Citigroup $22 → $21 Downgrades Neutral → Sell
05/01/2023 -23.48% Piper Sandler $18 → $19 Maintains Neutral
04/28/2023 0.68% Stifel $24 → $25 Maintains Hold
04/18/2023 -13.41% B of A Securities → $21.5 Downgrades Neutral → Underperform
02/07/2023 4.71% Citigroup $21 → $26 Maintains Neutral
01/09/2023 — B of A Securities Upgrades Underperform → Neutral
10/07/2022 — Citigroup Upgrades Sell → Neutral
09/26/2022 -19.45% Morgan Stanley → $20 Downgrades Equal-Weight → Underweight
08/01/2022 -19.45% Morgan Stanley $22 → $20 Maintains Equal-Weight
07/13/2022 -11.4% Morgan Stanley $32 → $22 Maintains Equal-Weight
05/02/2022 28.88% Morgan Stanley $35 → $32 Maintains Equal-Weight
04/18/2022 -14.22% Piper Sandler $19.5 → $21.3 Downgrades Neutral → Underweight
04/11/2022 40.96% Morgan Stanley $30 → $35 Maintains Equal-Weight
01/18/2022 20.82% Morgan Stanley $32 → $30 Maintains Equal-Weight
12/07/2021 28.88% Morgan Stanley $34 → $32 Maintains Equal-Weight
10/18/2021 28.88% B of A Securities $36 → $32 Downgrades Neutral → Underperform
10/11/2021 36.93% Morgan Stanley $37 → $34 Maintains Equal-Weight
08/03/2021 49.01% Morgan Stanley $40 → $37 Maintains Equal-Weight
07/09/2021 61.1% Morgan Stanley → $40 Downgrades Overweight → Equal-Weight
06/14/2021 44.99% Citigroup $30 → $36 Downgrades Neutral → Sell
03/25/2021 53.04% Morgan Stanley $33 → $38 Maintains Overweight
12/18/2020 -27.51% JP Morgan → $18 Downgrades Neutral → Underweight
11/10/2020 — Morgan Stanley Upgrades Equal-Weight → Overweight
10/26/2020 0.68% Morgan Stanley $24 → $25 Maintains Equal-Weight
09/29/2020 — ABN Amro Upgrades Sell → Hold
07/27/2020 -35.56% Piper Sandler $15 → $16 Maintains Neutral
07/24/2020 -11.4% Stifel $15 → $22 Maintains Hold
07/16/2020 -23.48% Scotiabank → $19 Downgrades Sector Outperform → Sector Perform
07/08/2020 -3.34% Morgan Stanley $18 → $24 Maintains Equal-Weight
05/19/2020 -27.51% Morgan Stanley $12 → $18 Maintains Equal-Weight
04/24/2020 -39.59% Stifel $14 → $15 Maintains Hold
04/13/2020 -47.64% Scotiabank $40 → $13 Upgrades Sector Perform → Sector Outperform
04/07/2020 -69.79% Piper Sandler $16.5 → $7.5 Maintains Neutral
03/18/2020 -43.62% Stifel $17 → $14 Maintains Hold
03/17/2020 -35.56% JP Morgan $39 → $16 Maintains Neutral
03/16/2020 -51.67% Morgan Stanley $45 → $12 Maintains Equal-Weight
03/13/2020 -55.7% Citigroup $40 → $11 Maintains Neutral
03/10/2020 -31.53% Stifel $40 → $17 Maintains Hold
03/09/2020 — B of A Securities Downgrades Buy → Underperform
01/30/2020 — Johnson Rice Reinstates → Buy
01/14/2020 56.26% Bernstein → $38.8 Initiates Coverage On → Market Perform
01/02/2020 61.1% Stifel $50 → $40 Downgrades Buy → Hold
12/31/2019 57.07% Cowen & Co. $42 → $39 Maintains Market Perform
12/10/2019 85.26% Citigroup $44 → $46 Maintains Neutral
10/18/2019 77.2% Citigroup $51 → $44 Maintains Neutral
10/07/2019 121.51% Morgan Stanley $65 → $55 Maintains Equal-Weight
09/11/2019 105.4% Citigroup $54 → $51 Maintains Neutral
07/12/2019 181.92% Morgan Stanley $75 → $70 Maintains Equal-Weight
07/10/2019 153.73% B of A Securities → $63 Upgrades Neutral → Buy
01/04/2019 165.81% Citigroup $76 → $66 Maintains Neutral
12/19/2018 202.05% Credit Suisse $105 → $75 Downgrades Outperform → Neutral
12/12/2018 218.16% JP Morgan $111 → $79 Maintains Neutral
12/11/2018 218.16% JP Morgan $111 → $79 Downgrades Overweight → Neutral
11/16/2018 — Guggenheim Upgrades Neutral → Buy
11/01/2018 — ABN Amro Upgrades Sell → Buy
10/29/2018 322.88% Morgan Stanley $115 → $105 Maintains Equal-Weight
10/29/2018 343.01% Stifel $117 → $110 Upgrades Hold → Buy
10/26/2018 322.88% Credit Suisse $122 → $105 Maintains Outperform
10/11/2018 363.15% Morgan Stanley $125 → $115 Maintains Equal-Weight
09/19/2018 403.42% Morgan Stanley → $125 Initiates Coverage On → Equal-Weight
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
09/18/2023 -19.45% 花旗集团 $21→$20 维护 卖
07/31/2023 -15.42% 派珀·桑德勒 $19→$21 维护 中性
2023/06/30 -15.42% 花旗集团 $22→$21 评级下调 中性→销售
05/01/2023 -23.48% 派珀·桑德勒 $18→$19 维护 中性
04/28/2023 0.68% Stifel $24→$25 维护 保持
04/18/2023 -13.41% B of A证券 →$21.5 评级下调 中性→表现不佳
02/07/2023 4.71% 花旗集团 $21→$26 维护 中性
01/09/2023 - B of A证券 升级 表现不佳的→中性
10/07/2022 - 花旗集团 升级 卖出→中性
09/26/2022 -19.45% 摩根士丹利 →$20 评级下调 等重→减码
08/01/2022 -19.45% 摩根士丹利 $22→$20 维护 等重
07/13/2022 -11.4% 摩根士丹利 $32→$22 维护 等重
05/02/2022 28.88% 摩根士丹利 $35→$32 维护 等重
04/18/2022 -14.22% 派珀·桑德勒 $19.5→$21.3 评级下调 中性→减持
04/11/2022 40.96% 摩根士丹利 $30→$35 维护 等重
01/18/2022 20.82% 摩根士丹利 $32→$30 维护 等重
12/07/2021 28.88% 摩根士丹利 $34→$32 维护 等重
10/18/2021 28.88% B of A证券 $36→$32 评级下调 中性→表现不佳
10/11/2021 36.93% 摩根士丹利 $37→$34 维护 等重
08/03/2021 49.01% 摩根士丹利 $40→$37 维护 等重
07/09/2021 61.1% 摩根士丹利 →$40 评级下调 超重→等重
2021/06/14 44.99% 花旗集团 $30→$36 评级下调 中性→销售
03/25/2021 53.04% 摩根士丹利 $33→$38 维护 超重
12/18/2020 -27.51% 摩根大通 →$18 评级下调 中性→减持
11/10/2020 - 摩根士丹利 升级 等重→超重
10/26/2020 0.68% 摩根士丹利 $24→$25 维护 等重
09/29/2020 - 荷兰银行 升级 销售→Hold
07/27/2020 -35.56% 派珀·桑德勒 $15→$16 维护 中性
07/24/2020 -11.4% Stifel $15→$22 维护 保持
07/16/2020 -23.48% 加拿大丰业银行 →$19 评级下调 行业表现优于→行业表现
07/08/2020 -3.34% 摩根士丹利 $18→$24 维护 等重
2020/05/19 -27.51% 摩根士丹利 $12→$18 维护 等重
04/24/2020 -39.59% Stifel $14→$15 维护 保持
04/13/2020 -47.64% 加拿大丰业银行 $40→$13 升级 行业表现优于→行业表现
04/07/2020 -69.79% 派珀·桑德勒 $16.5→$7.5 维护 中性
03/18/2020 -43.62% Stifel $17→$14 维护 保持
03/17/2020 -35.56% 摩根大通 $39→$16 维护 中性
03/16/2020 -51.67% 摩根士丹利 $45→$12 维护 等重
03/13/2020 -55.7% 花旗集团 $40→$11 维护 中性
03/10/2020 -31.53% Stifel $40→$17 维护 保持
03/09/2020 - B of A证券 评级下调 购买表现不佳的→
1/30/2020 - 约翰逊大米 恢复 →购买
2020/01/14 56.26% 伯恩斯坦 →$38.8 开始承保 →市场表现
1/02/2020 61.1% Stifel $50→$40 评级下调 购买→Hold
2019年12月31日 57.07% 考恩公司 $42→$39 维护 市场表现
2019年12月10日 85.26% 花旗集团 $44→$46 维护 中性
2019年10月18日 77.2% 花旗集团 $51→$44 维护 中性
2019/07/10 121.51% 摩根士丹利 $65→$55 维护 等重
2019/11/09 105.4% 花旗集团 $54→$51 维护 中性
2019年07月12日 181.92% 摩根士丹利 $75→$70 维护 等重
2019年07月10日 153.73% B of A证券 →$63 升级 中性→购买
2019年04月01日 165.81% 花旗集团 $76→$66 维护 中性
2018年12月19日 202.05% 瑞士信贷 $105→$75 评级下调 跑赢→中性
2018年12月12日 218.16% 摩根大通 $111→$79 维护 中性
2018年12月11日 218.16% 摩根大通 $111→$79 评级下调 超重→中性
2018年11月16日 - 古根海姆 升级 中性→购买
2018/11/01 - 荷兰银行 升级 卖出→买入
2018年10月29日 322.88% 摩根士丹利 $115→$105 维护 等重
2018年10月29日 343.01% Stifel $117→$110 升级 持有→购买
2018年10月26日 322.88% 瑞士信贷 $122→$105 维护 跑赢大盘
2018年10月11日 363.15% 摩根士丹利 $125→$115 维护 等重
2018年09月19日 403.42% 摩根士丹利 →$125 开始承保 →等重

What is the target price for Core Laboratories (CLB)?

核心实验室(CLB)的目标价格是多少？

The latest price target for Core Laboratories (NYSE: CLB) was reported by Citigroup on September 18, 2023. The analyst firm set a price target for $20.00 expecting CLB to fall to within 12 months (a possible -19.45% downside). 10 analyst firms have reported ratings in the last year.

核心实验室(纽约证券交易所代码：CLB)的最新目标价是由花旗集团于2023年9月18日报告的。这家分析公司将目标价定为20.00美元，预计CLB将在12个月内下跌(可能下跌19.45%)。去年有10家分析公司公布了评级。

What is the most recent analyst rating for Core Laboratories (CLB)?

核心实验室(CLB)的最新分析师评级是多少？

The latest analyst rating for Core Laboratories (NYSE: CLB) was provided by Citigroup, and Core Laboratories maintained their sell rating.

核心实验室(纽约证券交易所代码：CLB)的最新分析师评级由花旗集团提供，核心实验室维持其卖出评级。

When is the next analyst rating going to be posted or updated for Core Laboratories (CLB)?

核心实验室(CLB)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Core Laboratories, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Core Laboratories was filed on September 18, 2023 so you should expect the next rating to be made available sometime around September 18, 2024.

分析师在进行了广泛的研究后得出了股票评级，这些研究包括查阅公共财务报表，与核心实验室的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。核心实验室的上一次评级是在2023年9月18日提交的，所以你应该预计下一次评级将在2024年9月18日左右的某个时候公布。

Is the Analyst Rating Core Laboratories (CLB) correct?

分析师对核心实验室(CLB)的评级正确吗？

While ratings are subjective and will change, the latest Core Laboratories (CLB) rating was a maintained with a price target of $21.00 to $20.00. The current price Core Laboratories (CLB) is trading at is $24.83, which is out of the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的核心实验室(CLB)评级维持不变，目标价在21.00美元至20.00美元之间。核心实验室(CLB)目前的交易价格为24.83美元，超出了分析师的预测范围。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发